A Study to Evaluate the Effects of Natalizumab on Cognitive Functions in Patients with Relapsing Remitting Multiple Sclerosis (RRMS)
Latest Information Update: 09 Dec 2015
At a glance
- Drugs Natalizumab (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
Most Recent Events
- 09 Dec 2015 New trial record